FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a - 16 or 15d - 16 of
the Securities Exchange Act of 1934
For the month of June, 2004
Commission File Number: 1-10817
CELLTECH GROUP PLC
(Translation of registrant's name into English)
208 Bath Road, Slough, Berkshire SL1 3WE ENGLAND
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F X Form 40-F
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes No X
(If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-________).
| Enclosure: | 1. | Additional Listing announcement dated 08 June 2004 | |||
| Enclosure: | 2. | Additional Listing announcement dated 10 June 2004 | |||
| Enclosure: | 3. | Additional Listing announcement dated 11 June 2004 | |||
| Enclosure: | 4. | Additional Listing announcement dated 14 June 2004 | |||
| Enclosure: | 5. | Additional Listing announcement dated 15 June 2004 | |||
Enclosure No. 1
Celltech Group plc.
Application has been made to The UK Listing Authority and the London Stock
Exchange for a block listing of 363,636 Ordinary shares of 50p each under the
Celltech Executive Share Option Scheme, to trade on the London Stock Exchange
and to be admitted to the Official List upon issuance. The shares shall rank
pari passu with the existing issued shares of the Company.
Copies of this announcement are available from the office of Cazenove & Co. Ltd
for the period of 2 business days from the date hereof.
Enclosure No. 2
Celltech Group plc.
Application has been made to The UK Listing Authority and the London Stock
Exchange for a block listing of 363,636 Ordinary shares of 50p each under the
Celltech Executive Share Option Scheme, to trade on the London Stock Exchange
and to be admitted to the Official List upon issuance. The shares shall rank
pari passu with the existing issued shares of the Company.
Copies of this announcement are available from the office of Cazenove & Co. Ltd
for the period of 2 business days from the date hereof.
Enclosure No. 3
Celltech Group plc.
Application has been made to The UK Listing Authority and the London Stock
Exchange for a block listing of 363,636 Ordinary shares of 50p each under the
Celltech Executive Share Option Scheme, to trade on the London Stock Exchange
and to be admitted to the Official List upon issuance. The shares shall rank
pari passu with the existing issued shares of the Company.
Copies of this announcement are available from the office of Cazenove & Co. Ltd
for the period of 2 business days from the date hereof.
Enclosure No. 4
Celltech Group plc.
Application has been made to The UK Listing Authority and the London Stock
Exchange for a block listing of 363,636 Ordinary shares of 50p each under the
Celltech Executive Share Option Scheme, to trade on the London Stock Exchange
and to be admitted to the Official List upon issuance. The shares shall rank
pari passu with the existing issued shares of the Company.
Copies of this announcement are available from the office of Cazenove & Co. Ltd
for the period of 2 business days from the date hereof.
Enclosure No. 5
Celltech Group plc.
Application has been made to The UK Listing Authority and the London Stock
Exchange for a block listing of 363,636 Ordinary shares of 50p each under the
Celltech Executive Share Option Scheme, to trade on the London Stock Exchange
and to be admitted to the Official List upon issuance. The shares shall rank
pari passu with the existing issued shares of the Company.
Copies of this announcement are available from the office of Cazenove & Co. Ltd
for the period of 2 business days from the date hereof.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CELLTECH
GROUP PLC
(Registrant)
By: /s/
PETER ALLEN
Peter
Allen
Chief
Financial Officer
Dated: 21 June, 2004